Category Archives: Global News Feed

GHENT, Belgium, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that it has appointed Jackie Fielding, a former Vice President of Medtronic with more than 30 years of experience in the healthcare industry, as an independent Non-Executive Director of the Company, effective as of 1 September 2021 upon approval by the Board of Directors. She replaces Jason Hannon who is stepping down from the Board of Directors due to his return to California. The appointment of Ms. Fielding will be submitted for confirmation to the Company’s next General Meeting of Shareholders.

See more here:
Sequana Medical Appoints Jackie Fielding, Former Medtronic VP, to its Board of Directors

Orphazyme A/SCompany announcementNo. 21/2021CVR No.: 32266355

Link:
Orphazyme reports business highlights and financial results in Interim Report First Half 2021

Montrouge, France, August 31, 2021

Read this article:
DBV Technologies to Participate at Upcoming Investor Conferences

Oslo (Norway), 31 August 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first half-year 2021 results. Please find enclosed the report and presentation.Highlights

See more here:
PCI Biotech first half-year 2021 interim results

LONDON and RALEIGH, N.C., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference. The presentation will be available on-demand starting at 7:00 AM EDT / 12:00 PM BST on Monday, September 13, 2021.

See the original post:
Verona Pharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference

ROCKVILLE, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today reported financial results for the second quarter of 2021, and associated Company developments.

Go here to see the original:
Supernus Announces Second Quarter 2021 Financial Results

Diagnostics industry expert to lead commercialization of marketed products and drive global commercial expansion Diagnostics industry expert to lead commercialization of marketed products and drive global commercial expansion

Read the rest here:
Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 second quarter results on August 12, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sale.

Read the original post:
Aleafia Health to Announce 2021 Second Quarter Results

WESTMINSTER, Colo., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2021 financial results and provided a corporate update.

Go here to read the rest:
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Conference call and webcast today at 4:30 p.m. ET

More:
Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update